Recursion Pharmaceuticals releases open-source 300-gigabyte dataset to improve AI use in biotech Salt Lake City-based biotech company Recursion Pharmaceuticals released a dataset of genetically ...

This article checks, using both real and simulated data, the effectiveness of modern adaptive techniques to track the parameters of time-varying dynamic models. The real case studies concern a bone ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage ...

Recursion Pharmaceuticals, a Salt Lake City-based biotechnology company using machine learning artificial intelligence to develop new drugs, raised $121 million in its latest funding round.